Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

July 12, 2017

"Non-Hodgkin lymphoma is the seventh most common cancer in the United States, yet the majority of people who are diagnosed have very little information on the disease and how it may impact their lives.  This survey shows that it is critical that patients have resources to help them understand their condition and treatment options so they can communicate more effectively with their physicians," said David Henry, MD, Hematologist/Oncologist, Clinical Professor of Medicine, Pennsylvania Hospital, and the physician advisor for Framing Life With Lymphoma.  "In addition to providing information, physicians need to work with their patients to create a team-based approach to treatment.  Working as a team creates an environment where informed patients are more comfortable addressing their concerns and questions, which can have a positive impact on their overall treatment experience."    

Key Survey Findings:

70 percent of patients and 78 percent of physicians indicated that discussion materials (including brochures, checklists, online tools or digital information) would help them to have more effective conversations with their physician. About two in five of the surveyed patients (44 percent) do not ask all of their questions during visits, and the most common reason for not asking all questions is that they do not remember to ask them (25 percent).While physicians generally recognize patients' concerns about symptoms, side effects and the impact on daily life, they miss opportunities to discuss other issues that worry patients at initial diagnosis: 60 percent of patients indicated that treatment options were a main concern for them vs. 31 percent of physicians 51 percent of patients indicated that the impact on their family was a concern vs. 22 percent of physicians 48 percent of patients indicated that the chronic nature of iNHL was a concern vs. 15 percent of physicians Most physicians believe they are involving patients in treatment decisions (93 percent) and many patients (74 percent) said that they were involved. Additional findings are available in the survey results fact sheet available at: www.FramingLifeWithLymphoma.

SOURCE The Cancer Support Community